O'Connor Donal 4
4 · Theravance Biopharma, Inc. · Filed Nov 23, 2022
Insider Transaction Report
Form 4
O'Connor Donal
Director
Transactions
- Disposition to Issuer
Ordinary Shares
2022-11-22$10.50/sh−10,000$105,000→ 43,886 total
Footnotes (1)
- [F1]Represents ordinary shares tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's Dutch auction tender offer for up to $95 million of its ordinary shares.